Deerfield Management Company, L.P. (Series C) Humacyte, Inc. Transaction History

Deerfield Management Company, L.P. (Series C)

$4.04 Billion
Q4 2024

1 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q2 2024 Aug 14, 2024	BUY	$2.87 - $9.1 $926,582 - $2.94 Million	322,851 New	322,851 $1.55 Million

Others Institutions Holding HUMA

# of Institutions

172

Shares Held

40.8M

Call Options Held

553K

Put Options Held

942K

Black Rock Inc. New York, NY

7.14M
Shares

$10.6 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

5.6M
Shares

$8.35 Million
0.0% of portfolio
State Street Corp Boston, MA

4.61M
Shares

$6.87 Million
0.0% of portfolio
Woodline Partners LP San Francisco, CA

2.85M
Shares

$4.24 Million
0.11% of portfolio
Geode Capital Management, LLC Boston, MA

2.14M
Shares

$3.18 Million
0.0% of portfolio

View Full List

About Humacyte, Inc.

Ticker HUMA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 103,007,000
Market Cap $153M
Description
Humacyte, Inc. engages in the development and manufacture of off-the-shelf, implantable, and bioengineered human tissues for the treatment of diseases and conditions across a range of anatomic locations in multiple therapeutic areas. The company using its proprietary and scientific technology platform to engineer and manufacture human acellular ...

More about HUMA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Deerfield Management Company, L.P. (Series C), based on Form 13F filings with the SEC.

News

Stay updated on Deerfield Management Company, L.P. (Series C) with notifications on news.

Account